Clinical Efficacy of Dienogest for Symptomatic Adenomyosis
Journal of Clinical Medicine · 06.04.2026 · 15 (7) · 2763
DOI: 10.3390/jcm15072763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.04.2026. Verfasst von Yejin Kwon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-Ro 43-GIL, Songpa-gu, Seoul 05505, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT.
Abstract (Originalsprache)
Background
This study was conducted to assess whether medical treatment with dienogest (DNG) is effective in women with symptomatic adenomyosis.
Methods
This single-center, retrospective study included patients with symptomatic adenomyosis treated with oral DNG 2 mg daily. We evaluated the clinical symptoms, uterine volume, and serum CA-125 levels in these patients along with adverse events at baseline and after 3, 6, 12, 18, and 24 months of treatment, respectively.
Results
A total of 102 patients were analyzed. Among women with dysmenorrhea, 79.5% reported improvement in dysmenorrhea, and the mean time to improvement in dysmenorrhea was 7.18 months. Improvement in heavy menstrual bleeding was observed in 88.3% of patients, with a mean time to improvement in heavy menstrual bleeding of 5.44 months. We could see that the uterine volume decreased significantly after 18 months of treatment. Serum CA-125 levels declined significantly from 3 months onward and remained reduced through 24 months. More than half of the patients (55.8%) continued DNG without complications, whereas 31.3% discontinued treatment or switched to alternative therapies.
Conclusions
DNG effectively improved clinical symptoms and reduced uterine volume and serum CA-125 levels without serious adverse events in patients with symptomatic adenomyosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-Ro 43-GIL, Songpa-gu, Seoul 05505, Republic of Korea.
ORCID-Profile: Ju Hee Kim, Hee Dong Chae, Sa Ra Lee, Sung Hoon Kim
Förderung
- Ministry of Science and ICT
Zitieren
APA
Kwon, Y., Kim, J. H., Chae, H. D., Lee, S. R., & Kim, S. H. (2026). Clinical Efficacy of Dienogest for Symptomatic Adenomyosis. Journal of Clinical Medicine, 15(7), 2763. https://doi.org/10.3390/jcm15072763
Vancouver
Kwon Y, Kim JH, Chae HD, Lee SR, Kim SH. Clinical Efficacy of Dienogest for Symptomatic Adenomyosis. Journal of Clinical Medicine. 2026;15(7):2763. doi:10.3390/jcm15072763
BibTeX
@article{Kwon2026,
author = {Kwon, Yejin and Kim, Ju Hee and Chae, Hee Dong and Lee, Sa Ra and Kim, Sung Hoon},
title = {Clinical Efficacy of Dienogest for Symptomatic Adenomyosis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2763},
doi = {10.3390/jcm15072763}
}
EUVIMED